Special Communication: World Federation for Mental Health Conference Transcultural Mental Health in a Changing World: Building a Global Response - October 29 - 31, 2007 I recently attended this conference in Minneapolis, Minnesota which was organized by The World Federation for Mental Health (WFMH). This organization is devoted to... Read more
Recently, the medication Abilify (aripiprazole) was approved by the FDA for the treatment of schizophrenia in the adolescent population aged 13 - 17. This is a significant development in the treatment of schizophrenia, and I thought it would be interesting to explain how this medication received this new indication after being on... Read more
People with schizophrenia often have difficulty regularly taking their psychiatric medication, despite studies suggesting the great potential benefits of compliance to medication regiments. This issue is not limited to patients with psychotic disorders; in fact, several studies have found that a significant percentage of people with... Read more
In my last post, I discussed some of the changes in lifestyle that can help improve the heart health of people with schizophrenia. I'd like to continue my discussion about one particular area, smoking. Some research has shown that people with schizophrenia smoke almost twice as much as the population in general. Depending on what research... Read more
Recently, I posted a blog entry on the high rates of cardiovascular disease among people with schizophrenia. A reader asked if improvements in lifestyle for a relative with schizophrenia can help improve this situation. While I can't point to a large body of research that shows lifestyle changes reverse the higher risk of cardiac... Read more